Analysis of primary tumour DNA from patients progressing on AI therapy and subsequently treated with AI plus Irosustat identified somatic mutations in key BC associated genes, most notably ESR1, PIK3CA, and TP53. This evidence concerns the gene ESR1 and breast cancer.